In the eighth episode, Nicholas Saraceno examines how social media has reshaped where people get their health and supplement information, from AI-generated "wellness experts" running fabricated ads to registered dietitians and physicians building their own followings to counter it.

The panel closes by discussing which ingredient pairings show real biological synergy, whether brands are thinking about nutrient absorption competition, and why the budget-conscious end of the market may be the industry's most overlooked opportunity.

The company introduces Gut & Protein Optimizer, a probiotic-enzyme formula for protein utilization, and NMN 300 mg, an NAD+ precursor.

Built on Calanus Oil and ORIVO-verified fish oil, the concept targets brands seeking faster, differentiated omega-3 product development.

A mixed cell-culture and mouse study found that Ahiflower oil, a plant-based omega-3 source, reduced markers of endothelial inflammation, blood lipids, and platelet clotting activity at levels comparable to fish oil.

Nova Mentis's HT1 ingredient bypasses olive extraction, aiming to give formulators a more consistent supply of the polyphenol.

The appointment comes as the CDMO continues to expand its gummy, softgel, and fizzy tablet format offerings for brand partners.

At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.